# Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

> **NCT02706704** · PHASE2 · RECRUITING · sponsor: **American University of Beirut Medical Center** · enrollment: 32 (estimated)

## Conditions studied

- Uveitis
- Non-Infectious Uveitis

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT02706704
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2025-12
- **Final completion:** 2026-02
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02706704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02706704, "Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02706704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*